Related Experiment Videos

Steroid-induced hypertrophic cardiomyopathy in an infant

Pediatric Cardiology
|April 1, 1984
PubMed

Insights

High-dose steroids for infantile spasms may cause hypertrophic cardiomyopathy in infants. Echocardiograms are recommended during long-term steroid therapy to monitor heart function and structure.

Area of Science:

  • Pediatric Cardiology
  • Neonatal Medicine
  • Pharmacology

Background:

  • Infantile spasms and hypsarrhythmia are severe epilepsy syndromes in infants.
  • Corticosteroids are a primary treatment for infantile spasms.
  • Hypertrophic cardiomyopathy is a cardiac condition characterized by thickening of the heart muscle.

Observation:

  • A 14-month-old boy treated with high-dose steroids for infantile spasms developed hypertrophic cardiomyopathy.
  • Family history was negative for hypertrophic cardiomyopathy but positive for mitral valve prolapse.
  • Cardiac function normalized within 12 months after steroid dosage reduction and discontinuation.

Findings:

  • Long-term high-dose steroid therapy in infants can lead to reversible hypertrophic cardiomyopathy.
  • Steroid-induced cardiomyopathy may be a potential side effect in pediatric patients.
  • Echocardiography is crucial for monitoring cardiac changes during steroid treatment.

Implications:

  • Pediatricians and cardiologists should consider steroid-induced cardiomyopathy in infants on long-term corticosteroid therapy.
  • Regular echocardiographic monitoring is essential for early detection and management of cardiac abnormalities.
  • This case highlights the importance of risk-benefit assessment in pediatric steroid treatment.

Related Concept Videos